Vaccines for Children

Notice ID:

75D301-22-R-72134

Department/Ind. Agency:

HEALTH AND HUMAN SERVICES, DEPARTMENT OF

Sub-tier:

HEALTH AND HUMAN SERVICES, DEPARTMENT OF

Sub Command:

CDC NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES

Office:

CDC NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES

All Dates/Times are:

(utc-05:00) eastern standard time, new york, usa

Updated Published Date:

jan 20, 2022 10:25 am est

Original Published Date:

0000-00-00 00:00:00

Original Response Date:

jan 21, 2022 05:00 pm est

Inactive Policy:

15 days after date offers due

Updated Inactive Date:

feb 05, 2022

Original Inactive Date:

feb 05, 2022

Initiative:

• None***--***

Product Service Code:

6505 - drugs and biologicals

NAICS Code:

325412 - pharmaceutical preparation manufacturing

Original Set Aside:

The Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) requires the award of one or more indefinite quantity, indefinite delivery contracts for the purchase of the following pediatric vaccines and estimated quantities manufactured under a current establishment and product license issued by the U.S. Food and Drug Administration: ITEM SUPPLIES / SERVICES QTY / UNIT Dengue vaccine Min. Shelf Life: 12 Months Fed. Excise Tax: $0.75 per dose Maximum: 1M Doses Minimum: 100 Doses DTaP vaccine Min. Shelf Life: 12 Months Fed. Excise Tax: $2.25 per dose Maximum: 6.5M Doses Minimum: 100 Doses DTaP/Hep B/IPV vaccine Min. Shelf Life: 12 Months Fed. Excise Tax: $3.75 per dose Maximum: 5.38M Doses Minimum: 100 Doses DTaP-IPV vaccine Min. Shelf Life: 12 Months Fed. Excise Tax: $3.00 per dose Maximum: 3.5M Doses Minimum: 100 Doses DTaP-IP-HI vaccine Min. Shelf Life: 12 Months Fed. Excise Tax: $3.75 per dose Maximum: 7.5M Doses Minimum. 100 Doses DTaP-IPV-HIB-HEPB vaccine Min. Shelf Life: 12 Months Fed. Excise Tax: $4.50 per dose Maximum: 1.75M Doses Minimum. 100 Doses E-IPV vaccine Min. Shelf Life: 12 Months Fed. Excise Tax: $0.75 per dose Maximum: 4M Doses Minimum: 100 Doses Hepatitis A (pediatric) vaccine Min. Shelf Life: 12 Months Fed. Excise Tax: $0.75 per dose Maximum: 8.5M Doses Minimum: 100 Doses Hepatitis A&B (Age 18 only) vaccine Min. Shelf Life: 12 Months Fed. Excise Tax: $1.50 per dose Maximum: 100K Doses Minimum: 100 Doses Hepatitis B (pediatric/adol.) vaccine Min. Shelf Life: 12 Months Fed. Excise Tax: $0.75 per dose Maximum: 7.7M Doses Minimum: 100 Doses Hib vaccine Min. Shelf Life: 12 Months Fed. Excise Tax: $0.75 per dose Maximum: 8M Doses Minimum: 100 Doses Human Papillomavirus vaccine, Recombinant Min. Shelf Life: 12 Months Fed. Excise Tax: $0.75 per dose Maximum: 9M Doses Minimum: 100 Doses Measles, Mumps & Rubella (MMR) vaccine Min. Shelf Life: 12 Months Fed. Excise Tax: $2.25 per dose Maximum: 8M Doses Minimum: 100 Doses Meningococcal Conjugate (MCV4) vaccine Min. Shelf Life: 12 Months Fed. Excise Tax: $0.75 per dose Maximum: 6.5M Doses Minimum: 100 Doses Pneumococcal (13 Valent) Conjugate vaccine Min. Shelf Life: 12 Months Fed. Excise Tax: $0.75 per dose Maximum: 13M Doses Minimum: 100 Doses Pneumococcal (23 Valent) Polysaccharide vaccine Min. Shelf Life: 12 Months Fed. Excise Tax: N/A Maximum: 350K Doses Minimum: 100 Doses Rotavirus vaccine Min. Shelf Life: 12 Months Fed. Excise Tax: $0.75 per dose Maximum: 7M Doses Minimum: 100 Doses Tetanus and Diphtheria (Td) vaccine Min. Shelf Life: 12 Months Fed. Excise Tax: $1.50 per dose Maximum: 750K Doses Minimum: 100 Doses Tdap vaccine Min. Shelf Life: 12 Months Fed. Excise Tax: $2.25 per dose Maximum: 5.5M Doses Minimum: 100 Doses Varicella vaccine Min. Shelf Life: 12 Months Fed. Excise Tax: $0.75 per dose Maximum: 10M Doses Minimum: 10 Doses Measles, Mumps & Rubella and Varicella (MMR-V) vaccine Min. Shelf Life: 12 Months Fed. Excise Tax: $3.00 per dose Maximum: 3.4M Doses Minimum: 10 Doses Serogroup B Meningococcal vaccine Min. Shelf Life: 12 Months Fed. Excise Tax: $0.75 per dose Maximum: 2.5M Doses Minimum: 100 Doses The vaccines awarded under these contracts will be purchased for and by NCIRD's Immunization Awardees to support pediatric immunization programs as provided under Section 317(j) of the Public Health Service Act and Vaccine for Children (VFC) program, established pursuant to Section 13631 of the Omnibus Budget Reconciliation Act of 1993 (OBRA '93). This acquisition will be conducted in accordance with FAR Part 12, Acquisition of Commercial Items. Vaccines shall be shipped F.O.B. Destination to the 50 states and U.S. Territories. The period of performance shall be 4/1/2022 – 3/31/2023. Any questions regarding this notice shall be submitted in writing to Christina McMichael at wpn6@cdc.gov. Telephone inquiries will not be honored. Questions and Answers: 1) All questions received pertained to eligibility to submit a proposal. Answer: Eligibility is contingent on meeting the requirements listed in the solicitation, including being a vaccine manufacturer.

1600 CLIFTON ROAD

Atlanta , GA 30333

USA

Primary Point of Contacts:

Christina McMichael

Secondary Point of Contact:

Puli Hoxhaj